Nuveen Multistate Trust I has released its latest NPORT-P report, providing insights into its financial health and investment strategy. This filing is significant as it showcases the trust's total assets and liabilities, reflecting its ongoing commitment to transparency in the investment sector.
The report, filed on October 29, 2026, indicates that the trust has total assets of approximately $181 million, with liabilities of around $1.4 million. This results in net assets of about $179.6 million. The filing emphasizes the trust's focus on municipal bonds, particularly in Arizona, which is a critical area for investment in public projects.
Background
Nuveen Multistate Trust I, incorporated in Massachusetts, operates as an investment trust under the SEC Act of 1940. The trust's primary investment strategy revolves around municipal bonds, which are often favored for their tax-exempt status. The trust has undergone name changes in the past, most notably from Nuveen Flagship Multistate Trust I in 1996.
What the Filing Says
The NPORT-P filing reveals crucial financial metrics, including:
- Total Assets: $180,998,643
- Total Liabilities: $1,437,652
- Net Assets: $179,560,991
Additionally, the report highlights the trust's investment in various municipal bonds, including those issued by the Phoenix Industrial Development Authority and other entities in Arizona.
Impact
This filing may affect current and potential investors in Nuveen Multistate Trust I, as well as competitors in the municipal bond sector. The detailed financial information allows stakeholders to assess the trust's performance and investment strategy effectively.
What's Next
The filing does not say what happens next, leaving stakeholders to await further updates from the trust regarding its investment activities and future filings.
Read Next
Kinney Virginia reports stock transaction in NRG Energy
Fitzgerald Scott Michael reports share transaction at StubHub
Baker Eric Howard Acquires 18,130 Shares of StubHub Holdings
Hart Scott Barton Acquires Shares in NRG Energy, Inc.
Arcutis Biotherapeutics reports stock ownership update
Jazz Pharmaceuticals Director Sells 6,000 Shares in Transaction





